Guidelines for Counseling Persons Infected with Human T-Lymphotropic Virus Type I (HTLV-I) and Type II (HTLV-II)
暂无分享,去创建一个
W. Blattner | K. Fukuda | R. Khabbaz | S. Kleinman | E. Murphy | M. Busch | J. Epstein | L. Katz | E. Sloand | G. Nemo | J. Kaplan | R. Dodd | R. Gilcher | Craig A. Jackson | B. Poiesz | A. Williams | M. Ríos | M. Sullivan | Cielso Bianco | M. Rios | M. Busch
[1] W. Heneine,et al. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II , 1993, Journal of clinical microbiology.
[2] J. Drummond,et al. HTLV-II infection in Florida Indians. , 1993, AIDS research and human retroviruses.
[3] W. Heneine,et al. Detection of HTLV-II in breastmilk of HTLV-II infected mothers , 1992, The Lancet.
[4] T. M. Hartley,et al. Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study. , 1992, The Journal of infectious diseases.
[5] W. Hooper,et al. Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease. , 1992, Blood.
[6] G. Ehrlich,et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. , 1992, Blood.
[7] W. Blattner,et al. A prospective study of transmission by transfusion of HTLV‐I and risk factors associated with seroconversion , 1992, International journal of cancer.
[8] B. Hjelle,et al. Chronic neurodegenerative disease associated with HTLV-II infection , 1992, The Lancet.
[9] M. Ascher,et al. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II , 1992, Journal of clinical microbiology.
[10] T. M. Hartley,et al. Seroprevalence of HTLV-I and HTLV-II among Intravenous Drug Users and Persons in Clinics for Sexually Transmitted Diseases , 1992 .
[11] W. Blattner,et al. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. , 1992, The Journal of infectious diseases.
[12] B. Hjelle,et al. Evidence for Sexual Transmission of Human T Lymphotropic Virus Type II , 1992, Annals of Internal Medicine.
[13] G. Shaw,et al. Transmission of human T‐lymphotropic virus type I by blood components from a donor lacking anti‐p24: a case report , 1992, Transfusion.
[14] J. Coligan,et al. Differential antibody responsiveness to p19 Gag results in serological discrimination between human T lymphotropic virus type I and type II , 1991, Journal of medical virology.
[15] T. Takezaki,et al. Inhibitory effect of maternal antibody on mother‐to‐child transmission of human T‐lymphotropic virus type I , 1991, International journal of cancer.
[16] M. Shimoyama,et al. Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.
[17] T. M. Hartley,et al. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals , 1991, Journal of clinical microbiology.
[18] G. Ehrlich,et al. Transmission of Human T-Lymphotropic Virus Types I and II by Blood Transfusion: A Retrospective Study of Recipients of Blood Components (1983 Through 1988) , 1991 .
[19] B. Farber,et al. Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. , 1991, The American journal of medicine.
[20] E. Fontham,et al. Sensitivity of HTLV-I antibody assays for HTLV-II , 1991, The Lancet.
[21] W. Blattner,et al. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. , 1991, The Journal of infectious diseases.
[22] S. Kleinman,et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors , 1991, The Lancet.
[23] T. M. Hartley,et al. Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms , 1991, Journal of clinical microbiology.
[24] E. Murphy,et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. , 1991, American journal of epidemiology.
[25] C. Key,et al. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. , 1991, The Journal of infectious diseases.
[26] W. Heneine,et al. HTLV-II endemicity among Guaymi Indians in Panama. , 1991, The New England journal of medicine.
[27] Y. M. Chen,et al. Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[28] W. Blattner,et al. Infective dermatitis of Jamaican children: a marker for HTLV-I infection , 1990, The Lancet.
[29] W. Blattner,et al. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide , 1990, Journal of clinical microbiology.
[30] G. Shaw,et al. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection , 1990, The Lancet.
[31] R. Garruto,et al. Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis. , 1990, The Journal of infectious diseases.
[32] W. Blattner,et al. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. , 1990, The Journal of infectious diseases.
[33] B. Hjelle,et al. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. , 1990, Blood.
[34] S. Kwok,et al. Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns , 1990, Transfusion.
[35] S. Nagataki,et al. Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusion , 1990, Annals of neurology.
[36] R. Wilks,et al. Distinguishing between HTLV-I and HTLV-II by western blot , 1990, The Lancet.
[37] W. Blattner,et al. Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. , 1990, The Journal of infectious diseases.
[38] H. Nomura,et al. Antibody to p40tax protein of human T cell leukemia virus 1 and infectivity. , 1990, The Journal of infectious diseases.
[39] S. Izumo,et al. HTLV-I-associated myelopathy (HAM) treatment trials, retrospective survey and clinical and laboratory findings , 1989 .
[40] C. Mora,et al. HTLV-1 AND POLYMYOSITIS IN JAMAICA , 1989, The Lancet.
[41] J. Sninsky,et al. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. , 1989, Blood.
[42] E. Murphy,et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). , 1989, Annals of internal medicine.
[43] Chieh-Yu Liu,et al. Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion , 1989 .
[44] M. Ando,et al. Bronchoalveolar T-lymphocytosis in HTLV-1-associated myelopathy. , 1989, Chest.
[45] I. Maruyama,et al. CHRONIC INFLAMMATORY ARTHROPATHY ASSOCIATED WITH HTLV-I , 1989, The Lancet.
[46] J. Goedert,et al. Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I , 1989, International journal of cancer.
[47] W. Blattner,et al. Licensure of screening tests for antibody to human T-lymphotropic virus type I. , 1988, MMWR. Morbidity and mortality weekly report.
[48] G. de‐Thé,et al. Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. , 1988, The Journal of infectious diseases.
[49] P. Levine,et al. Adult T-cell leukemia/lymphoma in Brooklyn. , 1988, JAMA.
[50] T. Miyamoto,et al. HTLV-I carrier mothers with high-titer antibody are at high risk as a source of infection. , 1987, Japanese journal of cancer research : Gann.
[51] M. Ichijo,et al. Mother-to-child Transmission of Human T-cell Leukemia Virus Type-I , 1987 .
[52] M. Aboud,et al. Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia: a serologic study of hairy cell leukemia patients. , 1987, Leukemia.
[53] A. Fleming,et al. Antibodies to HTLV‐I in Nigerian blood‐donors, their relatives and patients with leukaemias, lymphomas and other diseases , 1986, International journal of cancer.
[54] H. Nomura,et al. Intrafamilial transmission of adult T cell leukemia virus. , 1986, The Journal of infectious diseases.
[55] W. Wachsman,et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. , 1986, The New England journal of medicine.
[56] N. Miyamoto,et al. Incidence of adult T‐cell leukemia‐lymphoma and its familial clustering , 1985, International journal of cancer.
[57] K. Okochi,et al. A Retrospective Study on Transmission of Adult T Cell Leukemia Virus by Blood Transfusion: Seroconversion in Recipients , 1984, Vox sanguinis.
[58] E. Jaffe,et al. The human T-cell leukemia-lymphoma virus in the southeastern United States. , 1983, JAMA.
[59] T. Suchi,et al. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. , 1982, Gan.
[60] M. Robert-Guroff,et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. , 1982, Science.
[61] M. Kikuchi,et al. Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic study , 1982, International journal of cancer.
[62] John D. Minna,et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.
[63] T. M. Hartley,et al. Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II? , 1992, Journal of acquired immune deficiency syndromes.
[64] S. Sabbatani,et al. Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (west Africa) , 1991, Journal of acquired immune deficiency syndromes.
[65] 片岡 隆策. Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits , 1991 .
[66] 楠原 浩一. Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I) : a fifteen-year follow-up study in Okinawa, Japan , 1991 .
[67] R. Janssen,et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. , 1990, Journal of acquired immune deficiency syndromes.
[68] D. Zella. HTLV-II infection in Italian drug abusers [letter] , 1990 .